Edinburgh

MARINA

ANCHOR

PrONTO

PIER

 

Visual stabilization (%)

 

88.7

 

94.6

 

96.4

 

95.0

 

90.3

Visual improvement (%)

15.0

33.8

40.3

35.0

13.1

No. of subjects

71

240

140

40

61

Mean injection frequency

5.4

12

12

5.6

6

Mean VA change in letters

+0.3

+7.2

+11.3

+9.3

-0.2

Snellen equivalent of 20/40 or better (%)

22.5

40.0

38.6

NA*

NA

Snellen equivalent of 20/200 or worse (%)

15.5

11.7

16.4

NA

NA

*NA: not available
Table 2: Primary outcomes at 12 months compared with other clinical trials.